Response to Yan et al. re: “Could Radioactive Iodine Be a Preferred Therapy for Graves' Hyperthyroidism Patients with Large Goiters? A Viewpoint from China”
Restricted accessLetterFirst published online November, 2023
Response to Yan et al. re: “Could Radioactive Iodine Be a Preferred Therapy for Graves' Hyperthyroidism Patients with Large Goiters? A Viewpoint from China”
YanS, LiX, YanB. Letter to the Editor: Could radioiodine be a preferred therapy for Graves' hyperthyroidism patients with large goiters? A viewpoint from China. Thyroid, 2023; 33(11);1380–1381; doi: 10.1089/thy.2023.0332
2.
RossDS, BurchHB, CooperDS, et al.2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid, 2016; 26(10);1343–1421; doi:10.1089/thy.2016.0229
3.
BilginerMC, OzdemirD, SeyrekFNC, et al.Evaluation of ultrasonographic and cytologic features of thyroid nodules in patients treated with radioactive iodine for hyperthyroidism. Diagn Cytopathol, 2020; 48(1):3–9; doi: 10.1002/dc.24319
4.
KitaharaCM, de GonzalezAB, BouvilleA, et al.Association of radioactive iodine treatment with cancer mortality in patients with hyperthyroidism. JAMA Intern Med, 2019; 179(8):1034–1042; doi: 10.1001/jamainternmed.2019.0891
5.
DanielsGH, RossDS. Radioactive iodine: A living history. Thyroid, 2023; 33(6);666–673; doi: 10.1089/thy.2022.0344
